Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 20, 2026 (2 months ago)

AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) bottle, Distributed by: AVKARE, Pulaski, TN, 38478, NDC 50268-068-15

Affected NDC 50268-0068-15

Compare with the code on your package — it is the most precise check available.

Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
carboxymethylcellulose sodium
NDC 50268-0068
, UNSPECIFIED FORM 5 mg/mL Solution/ Drops
Ophthalmic
AvPAK OTC
Recalling firm
Sterling Pharmaceutical Services LLC
NDC code
50268-068-15
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0855-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Sterling Pharmaceutical Services LLC

All 2026 recalls

Other sterility / contamination recalls from 2026

All sterility / contamination recalls